13F

Stock

Enlivex Therapeutics Ltd

Ticker not mapped · held by 35 managers

Reported value

$3.33M

Holders

35

+13 new · −3 exited

Holders’ est. mark

$157.1K

Price effect on 22 books still in the name

Largest holder

$1.38M

Diametric Capital, LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Diametric Capital, LP1.48M$1.38MNew
ARK Investment Management LLC628.3K$584.4KNew
PRELUDE CAPITAL MANAGEMENT, LLC225.7K$210KNew
TWO SIGMA INVESTMENTS, LP146.4K$136.2K$33.2KCut−$1.03K
UBS Group AG138.3K$128.6K$7.94KAdded$104K
BANK OF AMERICA CORP /DE/130.4K$121.3K$19.3KAdded$61.4K
Renaissance Technologies128.2K$119.2K$29.1KCut−$101.3K
JPMORGAN CHASE & CO125.9K$113.4K$418Added$111.9K
GOLDMAN SACHS GROUP INC102.1K$95KNew
XTX Topco Ltd100.4K$93.3K$14KAdded$49.9K
MORGAN STANLEY98.3K$91.5K$22.3KCut−$49.6K
GEODE CAPITAL MANAGEMENT, LLC80.6K$74.9KNew
Invesco Ltd.61.7K$57.3K$13.8KAdded$14.5K
Citadel28K$26K$5.81KAdded$8.02K
TWO SIGMA SECURITIES, LLC20K$18.6KNew
Prosperity Consulting Group, LLC17.6K$16.4K$4KAdded$4K
HARBOUR INVESTMENTS, INC.16K$14.9KNew
MILLENNIUM MANAGEMENT LLC11.8K$11KNew
NEUBERGER BERMAN GROUP LLC11K$10.2K$2.49KAdded$2.49K
SUSQUEHANNA INTERNATIONAL GROUP, LLP10.3K$9.59KNew
WELLS FARGO & COMPANY/MN9.38K$8.73K$2.08KAdded$2.27K
Tower Research Capital LLC (TRC)2.88K$2.68K$509Added$1.1K
SIMPLEX TRADING, LLC2.62K$2.43K$593Cut−$3.81K
MCGUIRE CAPITAL ADVISORS INC2.5K$2.33K$567Added$567
OSAIC HOLDINGS, INC.1.17K$1.09K$266Cut−$414
Arax Advisory Partners1.01K$945$231Added$231
Activest Wealth Management1K$930$227Added$227
Steward Partners Investment Advisory, LLC500$465$113Added$113
GROUP ONE TRADING LLC207$193New
TD Waterhouse Canada Inc.150$144New
Red Tortoise LLC150$140$35Added$35
US BANCORP \DE\50$47New
Virtu Financial LLC43.3K$40$10Added$7
SkyView Investment Advisors, LLC10K$9$2Added$2
Caitong International Asset Management Co., Ltd1$1New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.